Copyright
©The Author(s) 2020.
World J Clin Cases. Feb 6, 2020; 8(3): 594-599
Published online Feb 6, 2020. doi: 10.12998/wjcc.v8.i3.594
Published online Feb 6, 2020. doi: 10.12998/wjcc.v8.i3.594
Table 2 Second-line chemotherapy in metastatic bladder cancer
| Regimen | No of patients | OR% (95%CI) |
| Paclitaxel | 31 | 10 (0-26) |
| Docetaxel | 30 | 13 (4-30) |
| Ifosfamide | 56 | 20 (10-32) |
| Gemcitabine | 35 | 20 (10-36) |
| Paclitaxel and carboplatin | 44 | 16 (7-30) |
| Vinflunine | 51 | 18 (8-31) |
| Pemetrexed | 13 | 8 (NR) |
| Pemetrexed | 47 | 28 (16-43) |
- Citation: Jiang Q, Xie MX, Zhang XC. Complete response to trastuzumab and chemotherapy in recurrent urothelial bladder carcinoma with HER2 gene amplification: A case report. World J Clin Cases 2020; 8(3): 594-599
- URL: https://www.wjgnet.com/2307-8960/full/v8/i3/594.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i3.594